Sitagliptin Phos/Metformin Hcl
Brand name: Janumet
Rank #58 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$302.2M
Total Cost
329,315
Total Claims
$302.2M
Total Cost
13,179
Prescribers
$918
Cost per Claim
23,714
Beneficiaries
577,853
30-Day Fills
$23K
Avg Cost/Provider
25
Avg Claims/Provider
Share of Medicare Part D Spending
0.11%
of total Medicare Part D spending
$302.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $302.2M total
🔎 Data Overview
Average cost of $12,742 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Sitagliptin Phos/Metformin Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mohammad Chaudhry | Internal Medicine | Union City, NJ | 587 | $727K |
| 2 | Mohammed Rahman | Internal Medicine | Elmhurst, NY | 518 | $649K |
| 3 | Anthony Jung | Internal Medicine | Flushing, NY | 643 | $613K |
| 4 | Henry Chen | Internal Medicine | Brooklyn, NY | 453 | $584K |
| 5 | Martha Valdivia | Internal Medicine | New York, NY | 339 | $524K |
| 6 | Marcela Marani-Dicovskiy | Internal Medicine | Paterson, NJ | 405 | $507K |
| 7 | Cesar Trabanco | Endocrinology | Ponce, PR | 699 | $483K |
| 8 | Lisen Liu | Endocrinology | Flushing, NY | 922 | $472K |
| 9 | Amr Nayel | Family Practice | Astoria, NY | 287 | $404K |
| 10 | Rodolfo Guzman | Endocrinology | Bronx, NY | 250 | $387K |
| 11 | Marcos Parrilla Rios | Internal Medicine | San Lorenzo, PR | 319 | $373K |
| 12 | Razmik Ohanjanian | Internal Medicine | Glendale, CA | 601 | $362K |
| 13 | Thomas Mathew | Internal Medicine | New Hyde Park, NY | 234 | $347K |
| 14 | Herach Yadegarian | General Practice | Glendale, CA | 483 | $343K |
| 15 | Min Cai | Internal Medicine | Flushing, NY | 387 | $312K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 55 | Cariprazine Hcl (Vraylar) | $329.1M | 226,854 |
| 56 | Albuterol Sulfate (Albuterol Sulfate Hfa) | $312.2M | 7,904,120 |
| 57 | Rifaximin (Xifaxan) | $310.0M | 111,328 |
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology